Skip to main content
1025 search results for:

Teriflunomide 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. Open Access 16-05-2024 | Teriflunomide | Online First

    Sustained Effectiveness and Safety Over Time of Teriflunomide in Chinese Patients with Relapsing Multiple Sclerosis in the Greater Bay Area of China: Insights from Real-World Data

    Multiple sclerosis (MS) is a chronic autoimmune disease characterized by demyelination and axonal loss in the central nervous system (CNS) [ 1 ]. Currently, there is no known cure for MS, so disease-modifying therapies (DMTs) are commonly used to …

  2. 01-01-2024 | Teriflunomide | News

    Teriflunomide

    Acute pancreatitis
  3. Open Access 01-12-2023 | Multiple Sclerosis | OriginalPaper

    Teriflunomide as a therapeutic means for myelin repair

    The adult central nervous system (CNS) exhibits only limited regeneration capacities and impaired repair processes in patients with multiple sclerosis (MS) contribute to neurological disability and diminished quality of life on a long-term scale.

  4. 01-08-2023 | Teriflunomide | OriginalPaper

    Dimethyl Fumarate or Teriflunomide for Relapsing–Remitting Multiple Sclerosis: A Meta-analysis of Post-marketing Studies

    In the absence of head-to-head comparison trials, we aimed to compare the effectiveness of two largely prescribed oral platform disease-modifying treatments for relapsing–remitting multiple sclerosis, namely, dimethyl fumarate (DMF) and …

  5. Open Access 20-10-2023 | Teriflunomide | OriginalPaper

    Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study

    Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS) that usually debuts in young adults with a typical initial clinical course of relapses and remissions of neurological symptoms, leading to …

  6. 08-05-2023 | Multiple Sclerosis | OriginalPaper

    Matching-Adjusted Indirect Comparisons of Diroximel Fumarate, Ponesimod, and Teriflunomide for Relapsing Multiple Sclerosis

    Diroximel fumarate (DRF), ponesimod (PON), and teriflunomide (TERI) are oral disease-modifying therapies (DMTs) approved for the treatment of relapsing forms of multiple sclerosis (MS) [ 1 – 6 ]. The route and frequency of DMT administration are …

  7. 21-09-2023 | Multiple Sclerosis | News | Article

    Dimethyl fumarate associated with better RRMS outcomes than teriflunomide

    Treating relapsing–remitting multiple sclerosis patients with dimethyl fumarate versus teriflunomide is associated with more favorable clinical outcomes.

  8. 01-10-2022 | Multiple Sclerosis | News

    Teriflunomide

    Hypoaesthesia, hypertension and lack off efficacy: 3 case reports
  9. 01-10-2022 | Teriflunomide | News

    Teriflunomide

    Subacute aspiration pneumonia: case report
  10. 01-08-2023 | Teriflunomide | News

    Teriflunomide

    First report of lichenoid drug eruption: case report
  11. 06-09-2023 | Multiple Sclerosis | News | Article

    Teriflunomide reduces MS risk in patients with radiologically isolated syndrome

    The immunomodulating drug teriflunomide reduces the risk for developing multiple sclerosis in patients with radiologically isolated syndrome.

  12. Open Access 05-07-2023 | Teriflunomide | OriginalPaper

    Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study

    Multiple sclerosis (MS) is an immune-mediated, chronic, demyelinating disease of the central nervous system that affects approximately 2.8 million people worldwide [ 1 ]. Although the course of the disease is largely unpredictable, approximately …

  13. Open Access 01-02-2023 | Multiple Sclerosis | OriginalPaper

    Teriflunomide Concentrations in Cerebrospinal Fluid and Plasma in Patients with Multiple Sclerosis: A Pharmacokinetic Study

    Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system (CNS), with both inflammatory and degenerative features [ 1 , 2 ]. In 85–90% of patients the early phase is characterised by a relapsing-remitting (RR) …

  14. 01-06-2023 | Teriflunomide | News

    Teriflunomide

    First report of teriflunomide-induced Raynaud's phenomenon: case report
  15. 01-11-2021 | Multiple Sclerosis | News

    Teriflunomide

    Various toxicities: 9 case reports
  16. Open Access 11-04-2022 | Multiple Sclerosis | OriginalPaper

    Real-world outcomes of teriflunomide in relapsing–remitting multiple sclerosis: a prospective cohort study

    Multiple sclerosis (MS), an immune-mediated chronic demyelinating disease of the central nervous system, primarily manifests as recurrent attacks during early stage disease, followed by progressive disability [ 1 ]. Recently, numerous …

  17. 01-05-2023 | Multiple Sclerosis | News

    Teriflunomide

    Subacute cutaneous lupus erythematosus: case report
  18. 01-02-2021 | Multiple Sclerosis | News

    Teriflunomide

    DRESS syndrome: case report
  19. Open Access 13-07-2022 | Multiple Sclerosis | OriginalPaper

    Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece

    Multiple sclerosis (MS) is an autoimmune-mediated chronic, demyelinating disease of the central nervous system (CNS) that affects approximately 2.8 million people worldwide [ 1 ]. The severity of disease activity, the location of affected regions …

  20. 01-01-2021 | Appendectomy | News

    Teriflunomide

    Severe bone pain: 5 case reports

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.